Ciloa’s technology in a nature publication
Application of CIloa’s technology in Nature Scientific Reports. A nature.group publication describing some of the unique potential of Ciloa’s exosome…
Read More
Ciloa’s Chikungunya project retained for FUI funding
The Fond Unique Interministériel (FUI) has selected the ChikVax project carried by Ciloa, a biotech Company from Montpellier. The project…
Read More
Biovision 2015
Dr R. Mamoun will be attending the 2015 BioVision, The World Life Sciences Forum to be held April 15 and…
Read More
BIOFIT 2014
Meet Dr Robert Mamoun CEO/CSO of Ciloa BioFIT 2014, the Pharma and Biotech Event in Lille (France) on December 2-3,…
Read More
Ubistart Tour 2014
Dr. R. Mamoun CEO/CSO of Ciloa will attend UBISTART Tour 2014 (JULY 10, 2014 – New York Academy of Sciences…
Read More
BIO 2014 San Diego
Meet Dr Robert Mamoun CEO/CSO of Ciloa at BIO 2014 on June 23-26th 2014. Ciloa’s technology produces fully native membrane…
Read More